Sana Biotechnology, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Sana Biotechnology, Inc. (SANA) is 751.51M

According to Sana Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 751.51M. This represents a change of -20.61% compared to the average of 946.55M of the last 4 quarters.

Sana Biotechnology, Inc. (SANA) Historical Enterprise Value (quarterly & annually)

How has SANA Enterprise Value performed in the past?

The mean historical Enterprise Value of Sana Biotechnology, Inc. over the last ten years is 3.11B. The current 751.51M Enterprise Value has changed -75.83% with respect to the historical average. Over the past ten years (40 quarters), SANA's Enterprise Value was at its highest in in the December 2020 quarter at 6.10B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Sana Biotechnology, Inc. (SANA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sana Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sana Biotechnology, Inc. (SANA) Average Enterprise Value

How has SANA Enterprise Value performed in the past?

The current Enterprise Value of Sana Biotechnology, Inc. (SANA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sana Biotechnology, Inc. (SANA) Enterprise Value vs. Peers

How is SANA’s Enterprise Value compared to its peers?

Sana Biotechnology, Inc.’s Enterprise Value is less than Legend Biotech Corporation (3.58B), greater than Precision BioSciences, Inc. (137.79M), greater than Atara Biotherapeutics, Inc. (90.10M), greater than Allogene Therapeutics, Inc. (416.95M), greater than Century Therapeutics, Inc. (252.98M), greater than Fate Therapeutics, Inc. (277.53M), less than Intellia Therapeutics, Inc. (1.67B), less than Beam Therapeutics Inc. (2.80B), less than CRISPR Therapeutics AG (5.40B), less than Cullinan Therapeutics, Inc. (845.92M),

Build a custom stock screener for Sana Biotechnology, Inc. (SANA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sana Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sana Biotechnology, Inc. (SANA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sana Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.